Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers

1.00 hr(s) | CME , MOC , ABIM

Specialty: Gastric Cancer , GI Cancers , GEJ cancer

Therapeutic Area(s): Oncology , Gastroenterology

Release Date: June 22, 2021

Expiration Date: June 22, 2021

Location: Live Webcast

In recent years, immune checkpoint inhibitors have demonstrated durable responses and prolonged survival benefits in a spectrum of GI malignancies, including colorectal, esophageal, and gastric cancers. In this educational activity, experts will present a MasterClass featuring in-depth analysis of the current and emerging roles of immune checkpoint inhibitors in GI cancers, including their biological rationale and latest practice-informing clinical trial evidence, along with practical guidance on incorporating these agents into clinical practice.

Access this activity
Share via
Copy link
Powered by Social Snap